Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Depressive Symptoms in Danish Patients With Glioma and a Cancer-Free Comparison Group

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Preoperative distress predicts persistent pain after breast cancer treatment: A prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oncology to specialised palliative home care systematic transition: the Domus randomised trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. eHealth-mind the gap

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: It is well established that patients with glioma may experience adverse general (eg, headache) or focal symptoms (eg, personality changes) and neurocognitive deficits (eg, planning), but they may also experience severe emotional distress. We investigated the prevalence of depressive symptoms in patients with newly diagnosed glioma and in matched cancer-free persons.

METHODS: For this study, we recruited patients with glioma diagnosed within 12 months at all 4 neurosurgical clinics in Denmark. The cancer-free comparison group was identified through the Danish Central Person Register and matched on sex and age. Participants' depressive symptoms were evaluated using the Center for Epidemiologic Studies Depression Scale (CES-D; score range, 0-60), with a cutoff score ≥16 indicating moderate-to-severe depressive symptoms.

RESULTS: In this study, 363 of 554 patients with glioma and 481 of 1,304 cancer-free persons participated. Mean age of all patients was 55 years and 60% of the population was male. Mean scores for depressive symptoms were statistically significantly higher among patients with glioma, with a mean CES-D score of 10.9 (95% CI, 10.1-11.8) compared with 5.3 (95% CI, 4.7-5.8) among cancer-free persons (P<.0001). Overall, 92 patients with glioma (25%) and 30 cancer-free persons (6%) had moderate-to-severe depressive symptoms. After adjustment for marital status, education level, and comorbidity, the prevalence of depressive symptoms was 5 times higher among patients with glioma compared with cancer-free persons.

CONCLUSIONS: A substantially higher prevalence of moderate-to-severe depressive symptoms was identified in patients with glioma compared with cancer-free persons. This indicates the importance of programs to systematically identify and manage depressive symptoms in patients with glioma.

Original languageEnglish
JournalNational Comprehensive Cancer Network. Journal
Volume18
Issue number9
Pages (from-to)1222-1229
Number of pages8
ISSN1540-1405
DOIs
Publication statusPublished - Sep 2020

ID: 60936868